Division of Nephrology, Department of Medicine, McGill University Health Centre, Montreal, QC, Canada.
Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Transplantation. 2022 May 1;106(5):1051-1060. doi: 10.1097/TP.0000000000003842. Epub 2021 Jun 2.
In older adults (≥65), access to and outcomes following kidney transplantation (KT) have improved over the past 3 decades. It is unknown if there were parallel trends in re-KT. We characterized the trends, changing landscape, and outcomes of re-KT in older adults.
Among the 44,149 older kidney-only recipients (1995-2016) in the Scientific Registry of Transplant Recipients, we identified 1743 who underwent re-KT. We analyzed trends and outcomes (mortality, death-censored graft failure [DCGF]) by eras (1995-2002, 2003-2014, and 2015-2016) that were defined by changes to the expanded criteria donors and Kidney Donor Profile Index policies.
Among all older kidney-only recipients during 1995-2002, 2003-2014, 2015-2016 the proportion that were re-KTs increased from 2.7% to 4.2% to 5.7%, P < 0.001, respectively. Median age at re-KT (67-68-68, P = 0.04), years on dialysis after graft failure (1.4-1.5-2.2, P = 0.003), donor age (40.0-43.0-43.5, P = 0.04), proportion with panel reactive antibody 80-100 (22.0%-32.7%-48.7%, P < 0.001), and donation after circulatory death (1.1%-13.4%-19.5%, P < 0.001) have increased. Despite this, the 3-y cumulative incidence for mortality (22.3%-19.1%-11.5%, P = 0.002) and DCGF (13.3%-10.0%-5.1%, P = 0.01) decreased over time. Compared with deceased donor retransplant recipients during 1995-2002, those during 2003-2014 and 2015-2016 had lower mortality hazard (aHR = 0.78, 95% confidence interval, 0.63-0.86 and aHR = 0.55, 95% confidence interval, 0.35-0.86, respectively). These declines were noted but not significant for DCGF and in living donor re-KTs.
In older retransplant recipients, outcomes have improved significantly over time despite higher risk profiles; yet they represent a fraction of the KTs performed. Our results support increasing access to re-KT in older adults; however, approaches to guide the selection and management in those with graft failure need to be explored.
在过去的 30 年中,老年(≥65 岁)人群接受肾移植(KT)的机会和预后均有所改善。尚不清楚再 KT 是否存在类似的趋势。我们对老年人群再 KT 的趋势、变化情况和结局进行了描述。
在 Scientific Registry of Transplant Recipients 中,我们在 44149 名仅接受肾脏移植的老年(1995-2016 年)受者中,识别出 1743 名接受再 KT 的患者。我们根据扩大标准供者和 Kidney Donor Profile Index 政策的变化,通过时代(1995-2002 年、2003-2014 年和 2015-2016 年)来分析趋势和结局(死亡率、死亡风险调整移植物丢失)。
在 1995-2002 年、2003-2014 年和 2015-2016 年所有仅接受肾脏移植的老年受者中,再 KT 的比例分别从 2.7%增至 4.2%,再增至 5.7%,P<0.001。再 KT 时的中位年龄(67-68-68,P=0.04)、移植物失败后接受透析的年数(1.4-1.5-2.2,P=0.003)、供者年龄(40.0-43.0-43.5,P=0.04)、Panel Reactive Antibody 80-100 的比例(22.0%-32.7%-48.7%,P<0.001)和心脏死亡后捐献(1.1%-13.4%-19.5%,P<0.001)均增加。尽管如此,3 年累积死亡率(22.3%-19.1%-11.5%,P=0.002)和 DCGF(13.3%-10.0%-5.1%,P=0.01)的发生率仍随时间下降。与 1995-2002 年接受已故供者再次移植的受者相比,2003-2014 年和 2015-2016 年接受再次移植的受者死亡率的危险比(aHR=0.78,95%置信区间,0.63-0.86 和 aHR=0.55,95%置信区间,0.35-0.86)较低。这些趋势在 DCGF 和活体供者再 KT 中虽有提示但不显著。
尽管老年再移植受者的风险特征有所增加,但他们的预后在过去 30 年中显著改善;但他们仅占 KT 总数的一部分。我们的研究结果支持增加老年人群再 KT 的机会,但需要探索指导选择和管理的方法。